retatrutide clinical trials sign up A new trial from Eli Lilly and Company suggests its experimental triple hormone drug, retatrutide, could become one of the next major medications in the rapidly growing weight loss and diabetes Retatrutide for weight loss: Study

Research peptide vendors sell retatrutide labeled 'for research use only.' These products are not manufactured to pharmaceutical standards and are not tested or regulated by the FDA

This is an open secret in the peptide community

That comparison should have results by December 2026

Available at Pharmacies (Late 2027 to Early 2028) After approval, Eli Lilly needs a few more months to manufacture enough supply and negotiate insurance coverage

Retatrutide fails all of them: The FDA has said this directly: retatrutide "cannot be used in compounding under federal law." Any pharmacy making it is breaking federal law, no matter what their state laws say (Ohio Board of Pharmacy / FDA Letter)

For tht matter, it hasnt even finished human clinical trials